Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...
The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...
Amgen’s osteoporosis bone-forming drug Evenity (romosozumab) has been approved in Japan, ahead of a crunch review by advisers to the US regulator later this month. Evenity could have been on the ...
Bisphosphonates are currently the medication of choice for both prevention and treatment of glucocorticoid-induced osteoporosis. Teriparatide has been shown to be better than alendronate and might ...
Although bone loss is part of the aging process, some people lose too much bone or do not regain lost bone quickly enough. This condition is called osteoporosis, and is more common in postmenopausal ...